Is targeted biopsy really needed when performing systematic prostate biopsy to raise the detection rate for prostate cancer in patients with prostate-specific antigen ≤10 ng/mL?

Documenti analoghi

• Comparison of prostate cancer detection rates of various prostate biopsy methods for patients with prostate-specific antigen levels of <10.0 ng/mL in real-world practice
  di: Oh, Kyung Tak, et al.
  Pubblicazione: (2020)
• Impact of metabolic syndrome-related factors on the development of benign prostatic hyperplasia and lower urinary tract symptoms in Asian population
  di: Park, Jee Soo, et al.
  Pubblicazione: (2019)
• The association of family history of prostate cancer with the diagnosis of clinically significant prostate cancer in Korean population
  di: Jee Soo Park, et al.
  Pubblicazione: (2019-11-01)
• The association of family history of prostate cancer with the diagnosis of clinically significant prostate cancer in Korean population
  di: Park, Jee Soo, et al.
  Pubblicazione: (2019)
• Prostate-Specific Antigen Kinetics Following 5α-Reductase Inhibitor Treatment May Be a Useful Indicator for Repeat Prostate Biopsy
  di: Heo, Ji Eun, et al.
  Pubblicazione: (2018)